414 results on '"Ongini, Ennio"'
Search Results
2. The Role of the D 2 Dopamine Receptor (D 2R ) in A 2A Adenosine Receptor (A 2A R)-Mediated Behavioral and Cellular Responses as Revealed by A 2A and D 2 Receptor Knockout Mice
3. Nitric Oxide Release Combined with Nonsteroidal Antiinflammatory Activity Prevents Muscular Dystrophy Pathology and Enhances Stem Cell Therapy
4. Biologic Activity of Adenosine A2a Receptor Antagonists
5. Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol
6. Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy
7. Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice
8. Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: Implications for chronic treatments of neurodegenerative diseases
9. Nitric-oxide based nonsteroidal anti-inflammatory agents
10. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
11. The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye
12. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2α agonist, in preclinical models
13. The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages
14. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
15. An aging Interventions Testing Program: study design and interim report
16. Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages
17. Nuclear receptor peroxisome proliferator-activated receptor-γ is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen
18. Pharmacology of adenosine A2A receptors
19. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis
20. Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A 2A adenosine receptor blockade
21. Effects of adenosine derivatives on human and rabbit platelet aggregation: Correlation of adenosine receptor affinities and antiaggregatory activity
22. Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A2A adenosine receptor blockade
23. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimerʼs disease: old and new mechanisms of action
24. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid
25. Modulation of β-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures
26. Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
27. Nitric Oxide-Releasing Drugs: A Novel Class of Effective and Safe Therapeutic Agents
28. In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261
29. Sensitivity to selective adenosine A 1 and A 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
30. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain
31. [3H]SCH 58261, a Selective Adenosine A2A Receptor Antagonist, Is a Useful Ligand in Autoradiographic Studies
32. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury
33. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: Effect of ketanserin
34. Disclosing apoptosis in the CNS
35. D-1 Dopamine Receptors and Arousal
36. The role of the D2 dopamine receptor ([D.sub.2]R) in [A.sub.2A] adenosine receptor ([A.sub.2A]R)-mediated behavioral and cellular responses as revealed by [A.sub.2A] and [D.sub.2] receptor knockout mice
37. A β-carboline antagonizes benzodiazepine actions but does not precipitate the abstinence syndrome in cats
38. NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice
39. Intraocular Pressure–Lowering Activity of NCX 470, a Novel Nitric Oxide–Donating Bimatoprost in Preclinical Models
40. Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
41. Dopamine Receptor Subtypes and Arousal
42. Nitric Oxide (NO): An Emerging Target for the Treatment of Glaucoma
43. The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice
44. [3H]SCH 58261 labels functional adenosine A2A receptors in human neutrophil membranes
45. Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy
46. Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice
47. Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence
48. Treatment with a nitric oxide‐donating NSAID counteracts functional muscle ischemia in dystrophin‐deficient mdx mice
49. Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
50. Proton Pump Inhibitors and Low-Dose Aspirin Markedly Exacerbate NSAID-Induced Small Intestinal Injury: A Link to Dysbiosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.